[HTML][HTML] Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and …
…, TE Adeyeoluwa, OI Adeyomoye, R Adha, A Adibi… - The Lancet, 2024 - thelancet.com
Background Estimates of demographic metrics are crucial to assess levels and trends of
population health outcomes. The profound impact of the COVID-19 pandemic on populations …
population health outcomes. The profound impact of the COVID-19 pandemic on populations …
The projected economic and health burden of uncontrolled asthma in the United States
Rationale: Despite effective treatments, a large proportion of patients with asthma do not
achieve sustained asthma control. The “preventable” burden associated with lack of proper …
achieve sustained asthma control. The “preventable” burden associated with lack of proper …
Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global …
Background Asthma and atopic dermatitis (AD) are chronic allergic conditions, along with
allergic rhinitis and food allergy and cause high morbidity and mortality both in children and …
allergic rhinitis and food allergy and cause high morbidity and mortality both in children and …
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of …
…, B Aden, JB Adetunji, TE Adeyeoluwa, R Adha, A Adibi… - The Lancet, 2024 - thelancet.com
Background Understanding the health consequences associated with exposure to risk
factors is necessary to inform public health policy and practice. To systematically quantify the …
factors is necessary to inform public health policy and practice. To systematically quantify the …
Validation and utility testing of clinical prediction models: time to change the approach
… Amin Adibi, MSc 1 ; Mohsen Sadatsafavi, PhD, MD 1 ; John PA Ioannidis, MD, DSc 2 … Adibi
A, Sadatsafavi M, Ioannidis JPA. Validation and Utility Testing of Clinical Prediction Models: …
A, Sadatsafavi M, Ioannidis JPA. Validation and Utility Testing of Clinical Prediction Models: …
The acute COPD exacerbation prediction tool (ACCEPT): a modelling study
Background Accurate prediction of exacerbation risk enables personalised care for patients
with chronic obstructive pulmonary disease (COPD). We developed and validated a …
with chronic obstructive pulmonary disease (COPD). We developed and validated a …
[HTML][HTML] Value judgments in a COVID-19 vaccination model: a case study in the need for public involvement in health-oriented modelling
Scientific modelling is a value-laden process: the decisions involved can seldom be made
using ‘scientific’ criteria alone, but rather draw on social and ethical values. In this paper, we …
using ‘scientific’ criteria alone, but rather draw on social and ethical values. In this paper, we …
Moving beyond AUC: decision curve analysis for quantifying net benefit of risk prediction models
Statistical constructs such as ROC/AUC do not answer the critical question of how much
clinical utility a risk prediction model confers. This paper overviews decision curve analysis …
clinical utility a risk prediction model confers. This paper overviews decision curve analysis …
ACCEPT 2· 0: recalibrating and externally validating the acute COPD exacerbation prediction tool (ACCEPT)
Background The Acute Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
Prediction Tool (ACCEPT) was developed for individualised prediction of COPD exacerbations. …
Prediction Tool (ACCEPT) was developed for individualised prediction of COPD exacerbations. …
An individualized prediction model for long-term lung function trajectory and risk of COPD in the general population
Background Prediction of future lung function will enable the identification of individuals at
high risk of developing COPD, but the trajectory of lung function decline varies greatly among …
high risk of developing COPD, but the trajectory of lung function decline varies greatly among …